from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2684/arsA

LFCtreatmentdescriptionclass of inhibitor

-0.539

Amikacinug/mL Amikacintranslation

0.209

Cap5-10ug/mL Capreomycintranslation

0.840

Rox10-50 ug/mL Roxithromycintranslation

0.016

SM2-5 ug/mL Streptomycintranslation

-1.482

Tet5-10 ug/mL Tetracyclinetranslation

-1.102

Rif0.2-5ug/mL Rifampicintranscription

-0.912

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.381

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.358

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.279

CPZ10-50 ug/mL Chlorpromazinerespiration

1.027

Clofazimine10-13 ug/mL Clofaziminerespiration

0.525

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.984

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.383

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.785

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.530

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.027

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.156

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.159

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.199

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.107

KCN5-20 ug/mL Potassium cyaniderespiration

0.823

NaN30.2-2 mM Sodium aziderespiration

0.695

Nigericin50 uM Nigericinrespiration

-1.534

TRC10-150 ug/mL Triclosanrespiration

0.060

TRZ10-25 ug/mL Thioridazinerespiration

-1.976

Valinomycin0.5-10 uM Valinomycinrespiration

1.864

ZnSO42 mM ZnSO4respiration

-0.036

menadione6-10 ug/mL Menadionerespiration

-0.100

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.635

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.284

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

1.016

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.125

NRP_1Non-replicating persistence stage 1dosRassociated

1.224

Amp0.2mg/mL AmpicillincellWall

0.705

Cephalexin20-100 ug/mL CephalexincellWall

0.127

Cerulenin0.32-5 ug/mL CerulenincellWall

0.285

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.148

EMB10-20 ug/mL EthambutolcellWall

0.475

Eta12-40 ug/mL EthionamidecellWall

0.477

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.396

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.341

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.749

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.026

BZA0.12 mg/mL BenzamidearomaticAmides

-0.235

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.448

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.559

H2O24 mM hydrogen peroxideDNAdamaging

0.009

Levo10 ug/mL LevofloxacinDNAdamaging

0.009

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.957

Novobiocin10 ug/mL NovobiocinDNAdamaging

1.069

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.230

UVUV-irradiationDNAdamaging

0.260

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.427

Antimycin12.5-50 ug/mL Antimycin A?

0.440

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.244

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.349

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.048

PA8240.2-2 ug/mL PA-824?

0.555

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.354

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.907

Verapamil50 uM Verapamil?

0.516

mercaptoethanol2 mM 2-Mercaptoethanol?

0.630

methoxatin10-20 ug/mL Methoxatin?